Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Manal M Anwar

Showing results (31-40 of 52) with videos related to

Pageof 6
Sort By:
Mini Reviews in Medicinal Chemistry|March 31, 2018
Development of Promising Thiopyrimidine-Based Anti-cancer and Antimicrobial Agents: Synthesis and QSAR AnalysisYasmin M Syam, Manal M Anwar, Eman R Kotb, et al.
Bioorganic Chemistry|January 9, 2018
Synthesis and molecular docking study of new benzofuran and furo[3,2-g]chromone-based cytotoxic agents against breast cancer and p38α MAP kinase inhibitorsKamelia M Amin, Yasmin M Syam, Manal M Anwar, et al.
Acta Poloniae Pharmaceutica|October 24, 2013
Synthesis, cytotoxic evaluation and molecular docking study of novel quinazoline derivatives as PARP-1 inhibitorsKamelia M Amin, Manal M Anwar, Mohsen M Kamel, et al.
Bioorganic & Medicinal Chemistry|March 15, 2017
Synthesis and molecular docking studies of new furochromone derivatives as p38α MAPK inhibitors targeting human breast cancer MCF-7 cellsKamelia M Amin, Yasmin M Syam, Manal M Anwar, et al.
RSC Advances|May 2, 2022
New quinoxaline compounds as DPP-4 inhibitors and hypoglycemics: design, synthesis, computational and bio-distribution studiesYasmin M Syam, Manal M Anwar, Somaia S Abd El-Karim, et al.
Molecules (Basel, Switzerland)|July 3, 2019
A Comparative Study of the Anticancer Activity and PARP-1 Inhibiting Effect of Benzofuran-Pyrazole Scaffold and Its Nano-Sized Particles in Human Breast Cancer CellsManal M Anwar, Somaia S Abd El-Karim, Ahlam H Mahmoud, et al.
Molecules (Basel, Switzerland)|April 30, 2021
Discovery of New Coumarin-Based Lead with Potential Anticancer, CDK4 Inhibition and Selective Radiotheranostic Effect: Synthesis, 2D & 3D <i>QSAR</i>, Molecular Dynamics, In Vitro Cytotoxicity, Radioiodination, and Biodistribution StudiesMona O Sarhan, Somaia S Abd El-Karim, Manal M Anwar, et al.
Bioorganic Chemistry|September 23, 2018
Rational design and synthesis of new tetralin-sulfonamide derivatives as potent anti-diabetics and DPP-4 inhibitors: 2D & 3D QSAR, in vivo radiolabeling and bio distribution studiesSomaia S Abd El-Karim, Manal M Anwar, Yasmin M Syam, et al.
Molecules (Basel, Switzerland)|August 7, 2021
Synthesis, Characterization, In Vitro Anticancer Potentiality, and Antimicrobial Activities of Novel Peptide-Glycyrrhetinic-Acid-Based DerivativesGaber O Moustafa, Ahmed Shalaby, Ahmed M Naglah, et al.
Acta Poloniae Pharmaceutica|August 8, 2013
A novel class of substituted spiro [quinazoline-2,1'-cyclohexane] derivatives as effective PPAR-1 inhibitors: molecular modeling, synthesis, cytotoxic and enzyme assay evaluationKamelia M Amin, Manal M Anwar, Yasmin M Syam, et al.
Pageof 6

Showing results (31-40 of 52) with videos related to

Sort By:
Pageof 6
Mini Reviews in Medicinal Chemistry|March 31, 2018
Development of Promising Thiopyrimidine-Based Anti-cancer and Antimicrobial Agents: Synthesis and QSAR AnalysisYasmin M Syam, Manal M Anwar, Eman R Kotb, et al.
Bioorganic Chemistry|January 9, 2018
Synthesis and molecular docking study of new benzofuran and furo[3,2-g]chromone-based cytotoxic agents against breast cancer and p38α MAP kinase inhibitorsKamelia M Amin, Yasmin M Syam, Manal M Anwar, et al.
Acta Poloniae Pharmaceutica|October 24, 2013
Synthesis, cytotoxic evaluation and molecular docking study of novel quinazoline derivatives as PARP-1 inhibitorsKamelia M Amin, Manal M Anwar, Mohsen M Kamel, et al.
Bioorganic & Medicinal Chemistry|March 15, 2017
Synthesis and molecular docking studies of new furochromone derivatives as p38α MAPK inhibitors targeting human breast cancer MCF-7 cellsKamelia M Amin, Yasmin M Syam, Manal M Anwar, et al.
RSC Advances|May 2, 2022
New quinoxaline compounds as DPP-4 inhibitors and hypoglycemics: design, synthesis, computational and bio-distribution studiesYasmin M Syam, Manal M Anwar, Somaia S Abd El-Karim, et al.
Molecules (Basel, Switzerland)|July 3, 2019
A Comparative Study of the Anticancer Activity and PARP-1 Inhibiting Effect of Benzofuran-Pyrazole Scaffold and Its Nano-Sized Particles in Human Breast Cancer CellsManal M Anwar, Somaia S Abd El-Karim, Ahlam H Mahmoud, et al.
Molecules (Basel, Switzerland)|April 30, 2021
Discovery of New Coumarin-Based Lead with Potential Anticancer, CDK4 Inhibition and Selective Radiotheranostic Effect: Synthesis, 2D & 3D <i>QSAR</i>, Molecular Dynamics, In Vitro Cytotoxicity, Radioiodination, and Biodistribution StudiesMona O Sarhan, Somaia S Abd El-Karim, Manal M Anwar, et al.
Bioorganic Chemistry|September 23, 2018
Rational design and synthesis of new tetralin-sulfonamide derivatives as potent anti-diabetics and DPP-4 inhibitors: 2D & 3D QSAR, in vivo radiolabeling and bio distribution studiesSomaia S Abd El-Karim, Manal M Anwar, Yasmin M Syam, et al.
Molecules (Basel, Switzerland)|August 7, 2021
Synthesis, Characterization, In Vitro Anticancer Potentiality, and Antimicrobial Activities of Novel Peptide-Glycyrrhetinic-Acid-Based DerivativesGaber O Moustafa, Ahmed Shalaby, Ahmed M Naglah, et al.
Acta Poloniae Pharmaceutica|August 8, 2013
A novel class of substituted spiro [quinazoline-2,1'-cyclohexane] derivatives as effective PPAR-1 inhibitors: molecular modeling, synthesis, cytotoxic and enzyme assay evaluationKamelia M Amin, Manal M Anwar, Yasmin M Syam, et al.
Pageof 6